Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Redcentric shares jump on potential sale of data centre operations

(Sharecast News) - Shares in Redcentric jumped on Friday after the IT managed services provider confirmed press speculation about the potential sale of its data centres division. "Redcentric plc confirms that it is in the advanced stages of discussions concerning the potential sale of this business unit," the company said in a statement on Friday afternoon.

"However, there can be no certainty that a transaction will occur and further updates will be provided as appropriate."

Last year, Redcentric announced that it would create two autonomous business units, splitting its managed service provider operations from its data centre unit.

However, at the time of its half-year results in November, Redcentric said it continued to make upgrades to its data centres division, which generates around a quarter of group revenues after a period of solid growth.

The news comes just three days after Redcentric appointed a new chief financial officer. Tony Ratcliffe, who has over 25 years of senior financial management experience in technology and service companies, joined the firm with immediate effect, replacing CFO David Senior who announced his resignation in January.

Meanwhile in May, the company appointed non-executive director and former Vodafone exec Michelle Senecal De Fonseca as its new chief executive, replacing Peter Brotherton who stepped down after nine years at the helm.

Shares were nearly 15% higher at 140.05p by 1449.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.